Aperam 9 months figures show a 13.3% decline in sales to US$,635m, a decrease in EBITDA of 8% to US$396m, a slight increase in operating income (+7.8%) to US$262m and, lastly, a strong increase in net income to US$139m (vs US$76m). Net debt at the end of Q3 reached US$419m vs US$454m in H1. The group also indicated Q4 EBITDA should be "comparable to Q3", thus implying a full-year EBITDA in the €500m region. A dividend of US1.25 will be proposed at the AGM.
06 Nov 2015
Tough times for all players
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Tough times for all players
Aperam SA (APAM:WBO) | 0 0 (-0.4%) | Mkt Cap: 3,664m
- Published:
06 Nov 2015 -
Author:
Fabrice Farigoule -
Pages:
2
Aperam 9 months figures show a 13.3% decline in sales to US$,635m, a decrease in EBITDA of 8% to US$396m, a slight increase in operating income (+7.8%) to US$262m and, lastly, a strong increase in net income to US$139m (vs US$76m). Net debt at the end of Q3 reached US$419m vs US$454m in H1. The group also indicated Q4 EBITDA should be "comparable to Q3", thus implying a full-year EBITDA in the €500m region. A dividend of US1.25 will be proposed at the AGM.